US 9707220
Scopolamine for the treatment of depression and anxiety
granted A61KA61K31/46A61K45/06
Quick answer
US patent 9707220 (Scopolamine for the treatment of depression and anxiety) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/46, A61K45/06, A61K9/0073, A61P